Research advances in renal replacement therapy for hepatorenal syndrome

Hepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its cli...

Full description

Bibliographic Details
Main Authors: CHEN Li, MEI Yong, YANG Yibin
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2016-03-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=7280
id doaj-ca858a54927c41b6955eeaadf36400d7
record_format Article
spelling doaj-ca858a54927c41b6955eeaadf36400d72020-11-24T22:29:16ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562016-03-0132360560810.3969/j.issn.1001-5256.2016.03.046Research advances in renal replacement therapy for hepatorenal syndromeCHEN Li0MEI Yong1YANG Yibin2Department of Nephropathy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, ChinaDepartment of Nephropathy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, ChinaDepartment of Nephropathy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, ChinaHepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its clinical effect remains controversial. This review summarizes the research on HRS and advances in the clinical effect of renal replacement therapy for HRS, and points out that renal replacement therapy is not suitable as the conventional therapy for HRS, but it can be applied as the pre-transplantation transitional treatment for patients with a plan for liver transplantation, as well as the short-term treatment for non-transplantation patients who do not respond to vasoconstrictors.http://www.lcgdbzz.org/qk_content.asp?id=7280
collection DOAJ
language zho
format Article
sources DOAJ
author CHEN Li
MEI Yong
YANG Yibin
spellingShingle CHEN Li
MEI Yong
YANG Yibin
Research advances in renal replacement therapy for hepatorenal syndrome
Linchuang Gandanbing Zazhi
author_facet CHEN Li
MEI Yong
YANG Yibin
author_sort CHEN Li
title Research advances in renal replacement therapy for hepatorenal syndrome
title_short Research advances in renal replacement therapy for hepatorenal syndrome
title_full Research advances in renal replacement therapy for hepatorenal syndrome
title_fullStr Research advances in renal replacement therapy for hepatorenal syndrome
title_full_unstemmed Research advances in renal replacement therapy for hepatorenal syndrome
title_sort research advances in renal replacement therapy for hepatorenal syndrome
publisher Editorial Department of Journal of Clinical Hepatology
series Linchuang Gandanbing Zazhi
issn 1001-5256
1001-5256
publishDate 2016-03-01
description Hepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its clinical effect remains controversial. This review summarizes the research on HRS and advances in the clinical effect of renal replacement therapy for HRS, and points out that renal replacement therapy is not suitable as the conventional therapy for HRS, but it can be applied as the pre-transplantation transitional treatment for patients with a plan for liver transplantation, as well as the short-term treatment for non-transplantation patients who do not respond to vasoconstrictors.
url http://www.lcgdbzz.org/qk_content.asp?id=7280
work_keys_str_mv AT chenli researchadvancesinrenalreplacementtherapyforhepatorenalsyndrome
AT meiyong researchadvancesinrenalreplacementtherapyforhepatorenalsyndrome
AT yangyibin researchadvancesinrenalreplacementtherapyforhepatorenalsyndrome
_version_ 1725744178971803648